Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
$4.21
+5.7%
$3.17
$2.18
$7.90
$42.83M0.7523,499 shs15,945 shs
Old Republic International Corporation stock logo
ORI
Old Republic International
$36.60
-0.1%
$37.66
$31.17
$39.84
$9.05B0.731.22 million shs1.63 million shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
+7.13%+24.59%+39.70%+39.70%-29.68%
Old Republic International Corporation stock logo
ORI
Old Republic International
-0.08%-6.44%-0.26%-1.15%+20.28%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
1.4779 of 5 stars
0.04.00.00.03.31.70.6
Old Republic International Corporation stock logo
ORI
Old Republic International
4.7347 of 5 stars
2.54.04.21.63.42.51.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
0.00
N/AN/AN/A
Old Republic International Corporation stock logo
ORI
Old Republic International
3.00
Buy$42.0014.75% Upside

Current Analyst Ratings Breakdown

Latest ORI, CRDA, 1COV, BNR, and JMAT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/28/2025
Old Republic International Corporation stock logo
ORI
Old Republic International
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOutperform ➝ Outperform$42.00
4/25/2025
Old Republic International Corporation stock logo
ORI
Old Republic International
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$42.00
(Data available from 7/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
$70.67M0.64N/AN/A$7.39 per share0.57
Old Republic International Corporation stock logo
ORI
Old Republic International
$8.23B1.10$3.14 per share11.65$22.16 per share1.65
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
-$47.49M-$1.89N/AN/A-45.41%-38.33%-25.34%8/28/2025 (Estimated)
Old Republic International Corporation stock logo
ORI
Old Republic International
$852.80M$2.4614.8810.99N/A9.37%20.99%4.49%7/24/2025 (Estimated)

Latest ORI, CRDA, 1COV, BNR, and JMAT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/24/2025Q2 2025
Old Republic International Corporation stock logo
ORI
Old Republic International
$0.79N/AN/AN/A$2.18 billionN/A
6/6/2025Q1 2025
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
N/A-$0.17N/A-$0.17N/A$18.34 million
4/24/2025Q1 2025
Old Republic International Corporation stock logo
ORI
Old Republic International
$0.73$0.81+$0.08$0.98$2.03 billion$2.06 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
N/AN/AN/AN/AN/A
Old Republic International Corporation stock logo
ORI
Old Republic International
$1.163.17%N/A47.15%45 Years

Latest ORI, CRDA, 1COV, BNR, and JMAT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/23/2025
Old Republic International Corporation stock logo
ORI
Old Republic International
quarterly$0.293.11%6/6/20256/6/20256/16/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
N/A
3.02
2.76
Old Republic International Corporation stock logo
ORI
Old Republic International
0.27
0.24
0.24

Institutional Ownership

CompanyInstitutional Ownership
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
30.03%
Old Republic International Corporation stock logo
ORI
Old Republic International
70.92%

Insider Ownership

CompanyInsider Ownership
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
30.30%
Old Republic International Corporation stock logo
ORI
Old Republic International
1.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Burning Rock Biotech Limited Sponsored ADR stock logo
BNR
Burning Rock Biotech
1,39010.76 million7.50 millionNot Optionable
Old Republic International Corporation stock logo
ORI
Old Republic International
9,400247.16 million244.45 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Burning Rock Biotech stock logo

Burning Rock Biotech NASDAQ:BNR

$4.20 +0.23 (+5.65%)
Closing price 07/11/2025 03:58 PM Eastern
Extended Trading
$4.20 0.00 (0.00%)
As of 07/11/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Burning Rock Biotech Limited primarily develops and commercializes cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; and OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC. In addition, the company provides ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and brPROPHET, a pre-operative ctDNA detection and post-operative MRD calling for relapsed patients. Further, it has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA. Additionally, the company offers OncoMaster, an automatic NGS data analysis and report interpretation machine for in-hospital model. Burning Rock Biotech Limited was incorporated in 2014 and is headquartered in Guangzhou, China.

Old Republic International stock logo

Old Republic International NYSE:ORI

$36.60 -0.03 (-0.08%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$38.12 +1.52 (+4.15%)
As of 07/11/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Old Republic International Corporation, through its subsidiaries, engages in the insurance underwriting and related services business primarily in the United States and Canada. It operates through three segments: General Insurance, Title Insurance, and Republic Financial Indemnity Group Run-off Business. The General Insurance segment offers aviation, commercial auto, commercial multi-peril, commercial property, general liability, home and auto warranty, inland marine, travel accident, and workers' compensation insurance products; and financial indemnity products for specialty coverages, including errors and omissions, fidelity, directors and officers, and surety. This segment provides its insurance products to businesses, state and local government, and other institutions in transportation, commercial construction, healthcare, education, retail and wholesale trade, forest products, energy, general manufacturing, and financial services industries. The Title Insurance segment offers lenders' and owners' policies to real estate purchasers and investors based upon searches of the public records. This segment also provides escrow closing and construction disbursement services; and real estate information products, national default management services, and various other services pertaining to real estate transfers and loan transactions. The Republic Financial Indemnity Group Run-off Business segment offers private mortgage insurance coverage that protects mortgage lenders and investors from default related losses on residential mortgage loans made primarily to homebuyers. Old Republic International Corporation was founded in 1923 and is based in Chicago, Illinois.